Harding Loevner LP Repligen Corp Transaction History

Harding Loevner LP

$17.1 Billion
Q3 2024

A detailed history of Harding Loevner LP transactions in Repligen Corp stock. As of the latest transaction made, Harding Loevner LP holds 916,142 shares of RGEN stock, worth $132 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

916,142

Previous 632,979 44.73%

Holding current value

$132 Million

Previous $79.8 Million 70.87%

% of portfolio

0.8%

Previous 0.45%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $33.9 Million - $47.4 Million	283,163 Added 44.73%	916,142 $136 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $3.17 Million - $4.84 Million	-26,435 Reduced 4.01%	632,979 $79.8 Million
Q1 2024 May 15, 2024	SELL	$170.78 - $208.42 $9.71 Million - $11.9 Million	-56,885 Reduced 7.94%	659,414 $121 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $1.04 Million - $1.69 Million	-9,109 Reduced 1.26%	716,299 $129 Million
Q3 2023 Nov 14, 2023	BUY	$138.78 - $176.51 $101 Million - $128 Million	725,408 New	725,408 $115 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $6,737 - $10,760	-42 Reduced 23.73%	135 $25,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $15,635 - $25,022	97 Added 121.25%	177 $26,000
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $17,886 - $23,107	-146 Reduced 64.6%	80 $12,000
Q2 2020 Aug 14, 2020	SELL	$94.33 - $140.48 $2,546 - $3,792	-27 Reduced 10.67%	226 $28,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $19,392 - $24,164	253 New	253 $19,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harding Loevner LP, based on Form 13F filings with the SEC.

News

Stay updated on Harding Loevner LP with notifications on news.

Account

Harding Loevner LP Repligen Corp Transaction History